Ovarian cancer risk in postmenopausal women using estradiol-progestin therapy-a nationwide study

Climacteric

Volumn 16, Issue 1, 2012, Pages 48-53

  Koskela Niska, V ^a   Lyytinen, H ^a   Riska, A ^a   Pukkala, E ^b   Ylikorkala, O ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

Ovarian Cancer; Postmenopausal Hormone Therapy; Progestin Type; Risk; Route Of Administration

Indexed keywords

DROSPIRENONE; DYDROGESTERONE; ESTRADIOL; GESTAGEN; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MEGESTROL ACETATE; NORETHISTERONE; NORETHISTERONE ACETATE; PROGESTERONE; TRIMEGESTONE;

ADULT; AGED; ARTICLE; CANCER RISK; DISEASE ASSOCIATION; FEMALE; FINLAND; FOLLOW UP; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY CARCINOMA; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 84872445964     PISSN: 13697137     EISSN: 14730804     Source Type: Journal    
DOI: 10.3109/13697137.2012.663818     Document Type: Article

References (30)

1. Greiser CM, Greiser EM, Dö ren M. Menopausal hormone therapy and the risk of ovarian cancer: systematic review and meta-analysis. Hum Reprod Update 2007;13: 453-63 (Pubitemid 47303949)
2. Pearce CL, Chung K, Pike MC, Wu AH. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer 2009;115: 531-9
3. Annegers JF, Strom H, Decker DG, Dockerty MB, O' Fallon WM. Ovarian cancer. Incidence and case-control study. Cancer 1979;43: 723-9 (Pubitemid 9129113)
4. Luoto R, Auvinen A, Pukkala E, Hakama M. Hysterectomy and subsequent risk of cancer. Int J Epidemiol 1997;26: 476-83 (Pubitemid 27267766)
5. Riman T, Dickman PW, Nilsson S, et al. Hormone replacement therapy and the risk of invasive epithelial ovarian cancer in Swedish women. J Natl Cancer Inst 2002;94: 497-504 (Pubitemid 34411288)
6. Lacey JV, Brinton LA, Leitzmann MF, et al. Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP diet and health study cohort. J Natl Cancer Inst 2006;98: 1397-405 (Pubitemid 44530716)
7. Rossing MA, Cushing-Haugen KL, Wicklund KG, Doherty JA, Weiss NS. Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007;16: 2548-56 (Pubitemid 351196308)
8. Beral V, Bull D, Green J, Reeves G, and Million Women Study collaborators. Ovarian cancer and hormone replacement therapy in the Million Women Study. Lancet 2007;369: 1703-10 (Pubitemid 46755369)
9. M ø rch LS, Lø kkegaard L, Helms Andreasen A, Krü ger-Kj æ r S, Lidegaard Ø. Hormone therapy and ovarian cancer. JAMA 2009;302: 298-305
10. Kuhl H. Pharmacology of estrogens and progestogens: influence of different routes of administration. Climacteric 2005;8(Suppl): 3-63 (Pubitemid 41232429)
11. Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estrogen-only therapy. Obstet Gynecol 2006;108: 1354-60 (Pubitemid 44901007)
12. Lyytinen H, Pukkala E, Ylikorkala O. Breast cancer risk in postmenopausal women using estradiol - progestin therapy. Obstet Gynecol 2009;113: 65-73
13. Keskimä ki I, Aro S, Teperi J. Regional variation in surgical procedure rates in Finland. Scand J Soc Med 1994;22: 132-8 (Pubitemid 24191574)
14. Teppo L, Pukkala E, Lehtonen M. Data quality and quality control of a population-based cancer registry. Experience in Finland. Acta Oncol 1994;33: 365-9 (Pubitemid 24207996)
15. Karlan BY, Markman MA, Eifel PJ. Gynecologic cancers, section 4. In DeVita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles & Practice of Oncology, 7th edn. Philadelphia: Lippincott Williams & Wilkins, 2005: 1364-67
16. Rothman KJ, Greenland S. Modern Epidemiology, 2nd edn. Philadelphia: Lippincott-Raven Publishers, 1998: 264.
17. Auranen A, Hietanen S, Salmi T, Grénman S. Hormonal treatments and epithelial ovarian cancer risk. Int J Gynecol Cancer 2005;15: 692-700 (Pubitemid 41783072)
18. Hall JM, Couse JF, Korach KS. The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 2001; 276: 36869-72
19. Rahman KMW, Sarkar FH. Steroid hormone mimics: molecular mechanisms of cell growth and apoptosis in normal and malignant mammary epithelial cells. J Steroid Biochem Mol Biol 2002;80: 191-201 (Pubitemid 34234795)
20. Bu S, Yin D, Ren X, et al. Progesterone induces apoptosis and up-regulation of p53 expression in human ovarian carcinoma cell lines. Cancer 1997;79: 1944-50 (Pubitemid 27200378)
21. Rodriguez GC, Walmer DK, Kline M, et al. Effect of progestin on the ovarian epithelium of macaques: cancer prevention through apoptosis? J Soc Gynecol Invest 1998;52: 271-6 (Pubitemid 28427517)
22. Risch HA. Hormonal etiology of epithelial ovarian cancer, with a hypothesis considering the role of androgens and progesterone. J Natl Cancer Inst 1998;90: 1774-86 (Pubitemid 28559889)
23. Risch HA, Marrett LD, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histologic type. Results of a case-control study. Am J Epidemiol 1996;144: 363-72 (Pubitemid 26262199)
24. Purdie DM, Bain CJ, Siskind V, et al. Hormone replacement therapy and the risk of epithelial ovarian cancer. Br J Cancer 1999;81: 559-63 (Pubitemid 29458815)
25. Soegaard M, Jensen A, Hø gdall E, et al. Different risk factor profiles for mucinous and nonmucinous ovarian cancer: results from the Danish MALOVA study. Cancer Epidemiol Biomarkers Prev 2007;16: 1160-6 (Pubitemid 46984953)
26. La Vecchia C, Tavani A, Franceschi S, Parazzini F. Oral contraceptives and cancer. A review of evidence. Drug Saf 1996;14: 260-72 (Pubitemid 26128815)
27. Topo P, Luoto R, Hemminki E, Uutela A. Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland. Maturitas 1999;32: 141-5 (Pubitemid 29389728)
28. Hammar M, Brynhildsen J, Dabrosin L, et al. Hormone replacement therapy and previous use of oral contraceptives among Swedish women. Maturitas 1996;25: 193-9 (Pubitemid 26420894)
29. Sarantaus L, Vahteristo P, Bloom E, et al. BRCA1 and BRCA2 mutation among 233 unselected Finnish ovarian carcinoma patients. Eur J Hum Genet 2001;9: 424-30 (Pubitemid 32586065)
30. Auranen A, Pukkala E, Mä kinen J, Sankila R, Gré nman S, Salmi T. Cancer incidence in the first-degree relatives of ovarian cancer patients. Br J Cancer 1996;74: 280-4 (Pubitemid 26254144)